Borderline Personality Disorder (EUPD)

1. Clinical Overview

Summary

Borderline Personality Disorder (BPD), also known as Emotionally Unstable Personality Disorder (EUPD) in ICD-10, is a severe mental disorder characterised by a pervasive pattern of instability in interpersonal relationships, self-image, affects, and marked impulsivity beginning by early adulthood and present across various contexts. [1,2] The disorder affects approximately 1.6% of the general population, with higher prevalence in clinical settings (10-20% of psychiatric outpatients). [3,5]

Core features include frantic efforts to avoid real or imagined abandonment, unstable and intense interpersonal relationships alternating between extremes of idealisation and devaluation ("splitting"), identity disturbance with markedly unstable self-image, impulsivity in at least two potentially self-damaging areas, recurrent suicidal behaviour or self-harm, affective instability, chronic feelings of emptiness, inappropriate intense anger, and transient stress-related paranoid ideation or severe dissociation. [1,11] The DSM-5 requires five or more of nine criteria for diagnosis.

BPD is strongly associated with childhood adversity, particularly emotional neglect, sexual abuse, physical abuse, and invalidating environments. [2,8] The pathophysiology involves complex interactions between genetic vulnerability, neurobiological abnormalities (particularly in emotional processing circuits involving the amygdala and prefrontal cortex), and environmental factors. [6,8,9]

Treatment is primarily psychological, with Dialectical Behaviour Therapy (DBT) considered the gold-standard intervention. [4,16,18] Mentalisation-Based Therapy (MBT) and schema-focused therapy also demonstrate effectiveness. [17,20] Pharmacotherapy has a limited role and should target specific symptoms or comorbidities rather than BPD itself. [7] Long-term outcomes are more favourable than previously recognised, with remission rates of 85-90% at 10-year follow-up, though psychosocial functioning may remain impaired. [10,14]

The lifetime suicide completion rate is 8-10%, significantly higher than the general population, making risk assessment and crisis management paramount. [1,9] However, with appropriate treatment, most individuals with BPD can achieve symptom remission and improved quality of life.

Key Facts

Clinical Pearls

"Five of Nine for Diagnosis": DSM-5 requires 5 or more of 9 criteria. The diagnosis is dimensional, not categorical—symptom severity varies considerably. [1,11]

"Fear of Abandonment Drives Behaviour": Many seemingly chaotic behaviours (clinging, anger, self-harm) represent desperate attempts to avoid perceived abandonment. Understanding this fear is key to therapeutic engagement. [2,16]

"Splitting is Automatic, Not Malicious": The tendency to see people as "all good" or "all bad" is a primitive defence mechanism, not deliberate manipulation. This affects therapeutic relationships—expect alternating idealisation and devaluation. [1,2]

"DBT, Not Drugs": Medications have limited evidence in BPD and no medication is licensed for the disorder. DBT and other structured psychotherapies are the mainstay of treatment. [4,7,16]

"Validate Emotions, Not Behaviours": Therapeutic stance involves validating the patient's emotional experience while not reinforcing maladaptive behaviours (e.g., "I understand you're in terrible pain right now" vs. enabling repeated ED presentations). [16,18]

"Admission Often Worsens Outcomes": Psychiatric admission can foster regression, dependency, and iatrogenic harm. Crisis management should prioritise community-based interventions unless there is immediate life-threatening risk. [1,2]

"Recovery is Possible": BPD is not a lifelong sentence. Most patients achieve remission with appropriate treatment. Symptoms, particularly impulsivity and self-harm, tend to decrease with age even without treatment. [10,14]

"Screen for Trauma": The majority of BPD patients have trauma histories. Always screen for childhood abuse, neglect, and invalidation. Trauma-informed care is essential. [2,8,18]

---

2. Epidemiology

Prevalence

The Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), a large US study with 34,653 participants, found a lifetime prevalence of 5.9% using DSM-IV criteria, though this is higher than most other estimates. [5] More conservative estimates using structured clinical interviews suggest 1-2% in community samples. [2,3]

Demographics

Sex Distribution

• Female:Male ratio ≈ 3:1 in clinical samples [2,5]
• Community samples show more equal distribution (1.2:1), suggesting ascertainment bias [5]
• Males may be underdiagnosed or overrepresented in forensic/substance use settings [2]

Age

• Onset typically in late adolescence or early adulthood (18-25 years) [11,12]
• Symptoms often present in adolescence but diagnosis usually made in early adulthood [12]
• Prevalence decreases with age; older adults less commonly meet full criteria [10,14]

Ethnicity and Culture

• BPD appears across all cultures and ethnic groups [1,2]
• Prevalence rates similar across different countries and cultures [2]
• Cultural factors may influence symptom expression and help-seeking behaviour

Comorbidity

BPD rarely occurs in isolation. [4]

The high comorbidity burden significantly complicates treatment and worsens prognosis. [4]

Associated Risk Factors

Childhood Adversity [2,8]

• Sexual abuse: 40-70% of BPD patients
• Physical abuse: 25-73%
• Emotional abuse/neglect: 70-90%
• Witnessing domestic violence: 30-40%
• Early parental loss or separation: Elevated rates

Family History

• First-degree relatives have 5-fold increased risk of BPD [2]
• Increased rates of mood disorders, substance use, and antisocial personality disorder in families [2]
• Heritability estimated at 40-60% (twin and adoption studies) [2]

Neurodevelopmental Factors

• ADHD in childhood associated with increased BPD risk [2]
• Childhood temperamental traits: emotional reactivity, impulsivity, aggression [2]

---

3. Aetiology and Pathophysiology

Biosocial Model (Linehan)

The biosocial theory, developed by Marsha Linehan (creator of DBT), provides the most influential aetiological framework for BPD. [13,16]

Core Components:

1. Biological Emotional Vulnerability

   • High sensitivity to emotional stimuli (low threshold for emotional reactions)
   • Intense emotional responses (high amplitude)
   • Slow return to emotional baseline (prolonged physiological arousal)
   • Genetic and neurobiological basis

2. Invalidating Environment

   • Emotional expressions are dismissed, trivialised, or punished
   • Child's internal experiences are not reflected or validated
   • Emotional needs are ignored or met inconsistently
   • Child is told their emotions are "wrong" or "bad"
   • May be overt (abuse) or subtle (neglect, dismissiveness)

3. Transaction and Outcome

   • Emotionally vulnerable child in invalidating environment fails to learn:
     • How to label and regulate emotions
     • How to tolerate emotional distress
     • When to trust own emotional responses
     • How to form stable relationships
   • Child develops maladaptive coping strategies (self-harm, impulsivity, emotional avoidance)
   • Pattern perpetuates into adulthood

This model explains why both biological predisposition AND environmental factors are necessary for BPD development. [13,16]

Neurobiological Mechanisms

Exam Detail: Structural Neuroimaging [6,8,9]

Functional Connectivity

• Reduced connectivity between amygdala and prefrontal cortex [8,9]
• Impaired top-down regulation of emotional responses
• Hyperactive limbic system inadequately controlled by cortical regions

Neurotransmitter Systems [6,8,9,10]

1. Serotonin (5-HT)

   • Reduced serotonergic function
   • Associated with impulsivity, aggression, mood instability
   • Explains partial response to SSRIs for mood symptoms

2. Dopamine

   • Dysregulation in mesolimbic reward pathways
   • May contribute to anhedonia and emotional instability

3. Opioid System

   • Endogenous opioid dysregulation
   • May explain self-harm behaviour (pain analgesia during dissociation)

4. Oxytocin

   • Altered oxytocin system function [10]
   • Impaired social bonding and trust
   • Increased interpersonal hypersensitivity

Hypothalamic-Pituitary-Adrenal (HPA) Axis [7,8]

• HPA axis dysregulation common, especially in those with trauma history
• Altered cortisol responses to stress
• May contribute to emotional dysregulation and somatic symptoms

Genetic Factors

• Twin studies estimate heritability at 40-60% [2]
• No single "BPD gene" identified; likely polygenic inheritance
• Overlap with genetic risk for mood disorders and impulsivity traits [2]
• Gene-environment interactions crucial (e.g., serotonin transporter polymorphism × childhood abuse) [2]

Developmental Perspective

Attachment Theory [2,8]

• Disorganised attachment in childhood strongly predicts BPD
• Inconsistent, frightening, or absent caregiving creates internal working model of relationships as unstable and threatening
• "Fear of abandonment" reflects insecure attachment style
• Difficulty mentalising (understanding own and others' mental states) originates in early attachment disruption

Developmental Trauma

• Childhood trauma during critical periods of brain development alters neurodevelopmental trajectories [7,8]
• Emotional neglect may be as important as overt abuse [2,8]
• Cumulative trauma burden correlates with symptom severity [8]

---

4. Clinical Presentation

DSM-5 Diagnostic Criteria

A pervasive pattern of instability of interpersonal relationships, self-image, and affects, and marked impulsivity, beginning by early adulthood and present in a variety of contexts, as indicated by five (or more) of the following: [1,11]

Note: Do not include suicidal or self-mutilating behaviour covered by Criterion 5. [1]

ICD-10 Emotionally Unstable Personality Disorder

The ICD-10 uses the term "Emotionally Unstable Personality Disorder" (F60.3) with two subtypes:

F60.30 Impulsive Type

• Emotional instability
• Lack of impulse control
• Outbursts of violence or threatening behaviour

F60.31 Borderline Type (equivalent to DSM-5 BPD)

• All features of impulsive type, plus:
• Disturbances in self-image
• Chronic feelings of emptiness
• Intense, unstable relationships
• Tendency to self-destructive behaviour including suicidal gestures

Common Presentations

Emergency Department [1,2]

• Self-harm (cutting, burning, overdose)
• Suicidal ideation or attempt
• Acute distress following interpersonal conflict
• Dissociative episodes
• Substance intoxication
• Requesting admission

Outpatient Psychiatry

• Chronic mood instability
• Repeated relationship difficulties
• Work or academic dysfunction
• Treatment-resistant depression (often comorbid MDD)
• Request for medication changes

Primary Care

• Multiple medically unexplained symptoms
• Frequent consultations
• Difficult doctor-patient relationships
• Prescription drug seeking
• Requests for sick notes

Clinical Subtypes (Not Official but Clinically Recognised)

---

5. Clinical Examination

Mental State Examination (MSE)

The MSE in BPD is highly variable depending on the emotional state at assessment. [1,2]

• "empty"
• "numb"
• "angry"; difficulty labelling emotions | May describe rapid shifts: "I was fine this morning, then..." | | Affect (Objective) | Labile: rapidly shifting; intense: out of proportion to content; reactive to interviewer; may be congruent or incongruent with mood | Classic finding: mood reactivity and affective instability | | Thought Form | Usually coherent; may be circumstantial when emotionally dysregulated | Intact formal thought | | Thought Content | Suicidal ideation (common); self-harm urges; paranoid ideas about rejection/abandonment; rumination about relationships; low self-worth | Paranoid ideation is stress-related and transient, not fixed | | Perception | Usually normal; may report dissociation (depersonalisation, derealisation); pseudo-hallucinations rare; true hallucinations suggest comorbidity | Dissociation often described as "feeling unreal"
• "like watching myself"
• "time gaps" | | Cognition | Usually intact; may have poor concentration when distressed | No cognitive impairment is expected | | Insight | Variable; may fluctuate; can demonstrate good insight when calm but lose it when dysregulated | Ability to reflect on behaviour often present between crises |

Risk Assessment

Critical in Every BPD Assessment

Suicide Risk [1,9]

• 60-80% make at least one suicide attempt in lifetime
• 8-10% complete suicide
• Risk factors:
  • Comorbid depression
  • Substance use
  • Recent interpersonal loss
  • Childhood sexual abuse
  • Male sex
  • Older age at presentation

Self-Harm Risk

• 70-80% engage in non-suicidal self-injury (NSSI)
• Cutting most common method
• Functions: emotion regulation, self-punishment, communication of distress, ending dissociation
• Distinguish NSSI (no intent to die) from suicide attempt

Impulsivity Risk

• Assess current impulsive urges
• Reckless driving, unsafe sex, spending, substance use
• Impulsivity increases unpredictability of suicide risk

Risk Assessment Approach:

1. Ask directly about suicidal ideation, plan, intent, means
2. Assess previous attempts (method, medical severity, intent)
3. Identify current protective factors (relationships, responsibilities, future plans)
4. Consider impulsivity (even low intent can become lethal impulsively)
5. Assess access to means (medications, ligatures, firearms)
6. Formulate immediate vs. chronic risk

Challenge: Repeated ED presentations with suicidal ideation can lead to clinician desensitisation. Each assessment must be taken seriously—chronic suicidality does not negate acute risk. [1,2]

Diagnostic Challenges

Distinguishing BPD from:

---

6. Investigations

Clinical Diagnosis

BPD is a clinical diagnosis based on history and mental state examination. There are no laboratory or imaging tests. [1,2]

Structured Diagnostic Instruments:

In clinical practice, diagnosis is typically made through comprehensive psychiatric assessment without structured instruments. [1,2]

Assessment of Severity and Function

Symptom Severity:

• Zanarini Rating Scale for BPD (ZAN-BPD)
• Borderline Symptom List (BSL)

Quality of Life:

• WHO Quality of Life-BREF (WHOQOL-BREF)

Functional Impairment:

• Work and Social Adjustment Scale (WSAS)
• Global Assessment of Functioning (GAF)

Rule-Out Investigations

When to Investigate:

Key Point: Investigations are to exclude organic pathology and identify comorbidities, not to diagnose BPD. [1,2]

Psychological Testing

Not routinely required but may be useful:

• Personality assessment: Minnesota Multiphasic Personality Inventory (MMPI-2)
• Projective tests: Rorschach (less used now; limited evidence)
• Neuropsychological testing: If cognitive concerns (usually normal in BPD)

---

7. Management

Overview of Treatment Approach

Core Principles: [1,2,16,18]

1. Psychotherapy is the mainstay of treatment
2. Medications have limited role; target symptoms, not BPD itself
3. Manage crises with least restrictive intervention
4. Maintain consistent therapeutic boundaries
5. Avoid fostering dependency on services
6. Trauma-informed care is essential
7. Recovery-oriented: BPD is treatable, remission is achievable

Evidence-Based Psychotherapies

Exam Detail: #### 1. Dialectical Behaviour Therapy (DBT) — GOLD STANDARD

Developer: Marsha Linehan, 1993 [13,16]

Theoretical Basis:

• Biosocial theory (emotional vulnerability + invalidating environment)
• Synthesis of behavioural therapy and Zen mindfulness
• Dialectical philosophy: balance acceptance and change

Structure: [16,18]

• Individual therapy: Weekly 1-hour sessions with primary therapist
• Skills training group: Weekly 2-2.5 hour group sessions
• Phone coaching: Between-session crisis support (to generalise skills to real-life)
• Therapist consultation team: Weekly team meeting for therapist support and adherence

Duration: Typically 12 months (standard DBT); some programs 6 months

Four Skill Modules:

Evidence: [16,18,19]

• Multiple RCTs demonstrate efficacy
• Reduces suicide attempts by 50% compared to treatment-as-usual [16]
• Reduces self-harm, ED presentations, psychiatric hospitalisations [18,19]
• Improves depression, hopelessness, anger [16,18]
• Effects sustained at 12-month follow-up [16]

Limitations:

• Resource-intensive (requires trained therapists, group, phone coaching)
• High dropout rates (30-40% in some studies)
• Availability limited outside major centres

---

2. Mentalisation-Based Therapy (MBT)

Developers: Anthony Bateman and Peter Fonagy, 2004 [17]

Theoretical Basis:

• Attachment theory
• Mentalisation: capacity to understand own and others' mental states (thoughts, feelings, intentions)
• BPD reflects impaired mentalisation, especially under stress
• Origins in early attachment disruption

Structure: [17]

• MBT-Outpatient: Weekly individual therapy + weekly group therapy for 18 months
• MBT-Intensive: Day hospital program (partial hospitalisation) for 18 months
• Focus on "here and now" interactions and relationships

Techniques:

• Adopt "not-knowing" stance (curiosity, exploration)
• Stop and rewind: identify mentalising failures
• Focus on affect (emotions as key to understanding mental states)
• Use therapeutic relationship as vehicle for change

Evidence: [17]

• RCTs show reduced self-harm, suicide attempts, hospitalisations
• Comparable efficacy to DBT in head-to-head trial [17]
• May be particularly effective for attachment-related symptoms
• Effects sustained up to 8 years post-treatment [17]

Comparison with DBT:

• MBT: focus on understanding mental states; less structured skill-teaching
• DBT: focus on skill acquisition; more directive and structured
• Both effective; choice may depend on patient preference and availability [17]

---

3. Schema-Focused Therapy (SFT)

Developer: Jeffrey Young (adaptation of Cognitive Therapy) [20]

Theoretical Basis:

• Maladaptive schemas (core beliefs) develop from unmet childhood emotional needs
• BPD schemas: abandonment, mistrust, emotional deprivation, defectiveness, vulnerability

Structure:

• Individual therapy, typically 2-3 years
• Longer-term than DBT/MBT

Components:

• Identify schemas and coping styles (overcompensation, avoidance, surrender)
• Cognitive restructuring
• Experiential techniques (imagery rescripting, chair work)
• Behavioural pattern-breaking
• Limited reparenting (therapist provides corrective emotional experience)

Evidence: [20]

• RCTs show efficacy comparable to or exceeding DBT in some studies
• One study found SFT superior to DBT for BPD symptom reduction at 3-year follow-up [20]
• Effective for patients with trauma history
• May have lower dropout than DBT in some populations

---

4. Transference-Focused Psychotherapy (TFP)

Developers: Otto Kernberg and colleagues (psychodynamic approach)

Structure:

• Twice-weekly individual sessions, typically 1-2 years
• Focus on transference (patient's feelings towards therapist as window into relationships)

Evidence:

• RCTs show improvements in BPD symptoms, suicidality, and global functioning
• Less commonly used in UK NHS compared to DBT/MBT (resource constraints)

---

5. Systems Training for Emotional Predictability and Problem Solving (STEPPS)

Structure:

• Group-based skills training program (20 weeks)
• Involves family/friends as "reinforcement team"
• Psychoeducation + skills training

Evidence:

• Some evidence for symptom reduction
• Less intensive than DBT; may be useful as adjunct

---

6. Good Psychiatric Management (GPM)

Structure:

• Generalist approach for non-specialist settings
• Combines case management, supportive psychotherapy, and psychoeducation
• Less intensive than DBT/MBT

Evidence:

• Non-inferiority to DBT in some trials
• Pragmatic option when specialist therapies unavailable

---

Pharmacotherapy

CRITICAL: No medication is licensed for BPD. Drugs target symptoms or comorbidities, not the disorder itself. [1,7]

General Principles: [1,2,7]

• Avoid polypharmacy
• Time-limited trials (review every 3 months)
• Target specific symptoms
• Psychotherapy is first-line; medication is adjunctive at best
• Prescribe cautiously (overdose risk)

Medications by Target Symptom

Medications to AVOID

NICE Guidance (CG78): [1]

• Drug treatment should not be used specifically for BPD or for individual symptoms/behaviour associated with the disorder
• Consider short-term use of sedative medication during crisis (but avoid benzodiazepines if possible)
• Treat comorbid conditions (depression, PTSD, etc.) appropriately

American Psychiatric Association Guidelines:

• Medications may be used to target specific symptom domains
• Symptom-targeted pharmacotherapy is adjunctive to psychotherapy

Key Point: Overreliance on medication can be iatrogenic. Focus on psychotherapy. [1,2,7]

---

Crisis Management

Principles: [1,2]

1. Least restrictive intervention
2. Avoid reinforcing crisis presentations
3. Empower patient to use skills
4. Avoid admission unless life-threatening risk

Crisis Presentation Algorithm:

┌────────────────────────────────────────────────────────┐
│  PATIENT WITH BPD PRESENTS IN CRISIS                   │
│  (ED, crisis team, GP)                                 │
└────────────────────────────────────────────────────────┘
                       ↓
        ┌──────────────────────────────┐
        │  RISK ASSESSMENT             │
        │  - Suicidal ideation/plan    │
        │  - Means and intent          │
        │  - Impulsivity               │
        │  - Protective factors        │
        │  - Mental state              │
        └──────────────────────────────┘
                       ↓
        ┌──────────────────────────────────────┐
        │  IMMEDIATE LIFE-THREATENING RISK?    │
        │  - High intent + plan + means        │
        │  - Severe overdose/self-harm         │
        │  - Acute psychosis                   │
        └──────────────────────────────────────┘
                ↓                    ↓
              YES                   NO
                ↓                    ↓
    ┌──────────────────────┐   ┌──────────────────────────┐
    │  ADMISSION            │   │  COMMUNITY MANAGEMENT    │
    │  - Medical if needed  │   │  - Validate distress     │
    │  - Psychiatric if:    │   │  - Avoid invalidation    │
    │    * Imminent risk    │   │  - Brief intervention    │
    │    * No community     │   │  - Crisis plan review    │
    │      support          │   │  - Coping strategies     │
    │  - SHORT stay         │   │  - Safety plan           │
    │  - Discharge planning │   │  - Follow-up (24-48h)    │
    │    from day 1         │   │  - Contact crisis team   │
    └──────────────────────┘   │  - GP follow-up          │
                                │  - Refer to psych if new │
                                └──────────────────────────┘

Crisis Plan (Developed Collaboratively in Advance): [16,18]

• Identify triggers (e.g., relationship conflict, anniversary of trauma)
• Early warning signs (e.g., increased urge to self-harm, dissociation)
• Coping strategies to try first (DBT skills: distress tolerance techniques)
• Who to contact (crisis team number, therapist, trusted friend)
• What NOT to do (e.g., don't go to ED unless medical emergency)
• When to go to ED (genuine life-threatening risk)

Therapeutic Stance in Crisis:

✅ DO:

• Validate emotions: "I can see you're in a lot of pain right now"
• Reinforce skills: "What skills have you tried?" "What else could you try?"
• Set boundaries: "I can give you 15 minutes now; then you'll need to use your crisis plan"
• Provide consistency: Same response each time (prevents reinforcement of crises)

❌ DON'T:

• Invalidate: "You're just being manipulative" (This is stigmatising and incorrect)
• Rescue: Admit to hospital every time, take over problem-solving
• Punish: Discharge patient angrily from service
• Reinforce: "Come back anytime you're upset" (inadvertently rewards crisis presentations)

---

Admission to Hospital

Indications: [1,2]

• Acute, severe, and persistent suicidal ideation with plan, means, and intent
• Suicide attempt requiring medical treatment
• Acute psychotic episode (rare in BPD; consider comorbidity)
• Severe comorbid disorder requiring admission (e.g., severe depression, mania)

Why Admission is Often Unhelpful in BPD: [1,2]

• Fosters regression and dependency
• Removes patient from real-life environment where skills must be practised
• Can reinforce crisis behaviour (admission = escape from distress)
• Iatrogenic harm: exposure to more unwell patients, institutionalisation
• Long admissions associated with worse outcomes

If Admission Necessary:

• Keep as short as possible (days, not weeks)
• Focus on safety and stabilisation only
• Discharge planning from day 1
• Link to community team before discharge
• Avoid "revolving door" pattern

---

Long-Term Management and Recovery

Stepped Care Approach:

Role of Different Services:

• Primary Care: Identify and refer; provide continuity; manage physical health
• Community Mental Health Team (CMHT): Assessment, care coordination, crisis management
• Psychology/Psychotherapy Services: Deliver evidence-based psychotherapy (DBT, MBT, etc.)
• Crisis Team: Out-of-hours support; home treatment as alternative to admission
• Inpatient Services: Brief admission for acute risk only

Supporting Recovery: [10,14]

• Psychoeducation about BPD and recovery
• Peer support (patient groups, online forums)
• Vocational rehabilitation (return to work/education)
• Address comorbidities (substance use, PTSD, eating disorders)
• Physical health monitoring (BPD patients have higher rates of obesity, diabetes, cardiovascular disease)

---

8. Complications

Of the Disorder

Of Treatment

Psychotherapy:

• Therapeutic ruptures (splitting, intense transference)
• Dependency on therapist
• Distress during trauma processing (if trauma-focused work)
• Dropout (30-40% in some studies)

Pharmacotherapy:

• Medication side effects (weight gain, sedation, metabolic syndrome with antipsychotics)
• Overdose (intentional or impulsive)
• Dependence (benzodiazepines)
• False reassurance that medication will "cure" BPD (unrealistic expectations)

Hospitalisation:

• Regression and dependency
• Institutionalisation
• Iatrogenic harm (exposure to more severely unwell patients; coercive interventions)
• Disruption to real-life functioning (work, relationships)

Iatrogenic Harm from Stigma

Pejorative attitudes from healthcare staff: [1,2]

• Labelling patients as "difficult"
  • "manipulative"
  • "attention-seeking"
• Dismissing genuine distress
• Reluctance to engage therapeutically
• Punitive responses (e.g., discharge from service)

Impact:

• Worsens symptoms
• Increases risk
• Reduces help-seeking
• Contributes to poor outcomes

Mitigation:

• Education for healthcare staff about BPD
• Supervision and reflective practice
• Understanding behaviour as driven by fear and emotional pain, not malice
• Trauma-informed care

---

9. Prognosis and Outcomes

Natural History

Longitudinal Course: [10,14]

McLean Study of Adult Development (MSAD): [10]

• 10-year follow-up of 290 BPD patients
• Remission: 85% achieved 2-year remission by 10 years
• Recurrence: 10-15% (lower than mood disorders)
• Functional recovery: Slower than symptomatic remission; only 50% achieved good psychosocial functioning

Findings:

• Symptoms, particularly impulsivity and self-harm, decrease significantly over time
• Affective symptoms and relationship difficulties more persistent
• Many patients able to maintain work and relationships by middle age [10,14]

Prognostic Factors

Good Prognosis: [2,10]

• Higher IQ and education
• Stable employment history
• Absence of childhood sexual abuse
• Later age of onset
• Less severe baseline symptoms
• Absence of comorbid PTSD or substance use
• Engagement in effective psychotherapy
• Strong social support

Poor Prognosis: [2,10]

• Severe childhood trauma (especially sexual abuse)
• Comorbid substance use disorder
• Comorbid PTSD
• Low socioeconomic status
• Chronic self-harm
• Multiple suicide attempts
• Male sex (higher suicide completion)
• Comorbid antisocial personality disorder

Mortality

Suicide: [1,9]

• Lifetime risk: 8-10% (100x higher than general population)
• Standardised mortality ratio (SMR): 40-50
• Risk highest in young adults and those with comorbid depression
• Method: Overdose most common; hanging also frequent

Other Causes:

• Accidents (impulsivity, substance use)
• Medical complications (chronic self-harm, substance use)
• Cardiovascular disease (lifestyle factors, metabolic syndrome from medications)

With Treatment

Effect of Evidence-Based Psychotherapy: [16,17,18,19,20]

Key Point: Treatment accelerates natural improvement and reduces morbidity and mortality. [10,14]

Functional Outcomes

Work/Education:

• Many patients able to complete education and maintain employment by middle age
• High-functioning BPD: may excel in careers
• Low-functioning BPD: chronic unemployment, disability benefits

Relationships:

• Relationship stability improves with age
• Many patients able to form stable partnerships and parent successfully
• Some continue to struggle with interpersonal relationships

Quality of Life:

• Significant improvement with treatment and time
• Residual symptoms common but less severe
• Patients often describe "learning to live with" emotional sensitivity

---

10. Prevention and Public Health

Primary Prevention

Target: Reduce incidence of BPD

Strategies:

• Public health campaigns against child abuse and neglect
• Parenting programs promoting secure attachment and emotional validation
• Early identification of at-risk children (trauma exposure, emotional dysregulation)
• School-based programs teaching emotion regulation skills
• Reduce societal stigma around mental illness and help-seeking

Evidence: Limited direct evidence for BPD prevention, but trauma reduction likely reduces incidence. [2,8]

Secondary Prevention

Target: Early detection and intervention

Strategies:

• Screen adolescents and young adults in mental health services for emerging BPD traits [12]
• Early intervention programs for adolescents with BPD symptoms (e.g., DBT-A: DBT for Adolescents) [19]
• Reduce delay between symptom onset and diagnosis/treatment
• Address comorbidities early (depression, substance use, eating disorders)

Evidence:

• Emerging evidence that early DBT in adolescents reduces self-harm and suicidal ideation [19]
• Early intervention may alter trajectory of disorder [12]

Tertiary Prevention

Target: Reduce disability and complications

Strategies:

• Provide evidence-based psychotherapy (DBT, MBT, SFT)
• Crisis planning to reduce ED presentations and hospitalisations
• Address comorbidities
• Prevent iatrogenic harm (avoid over-medication, repeated admissions)
• Promote recovery and psychosocial functioning

---

11. Evidence and Guidelines

Key Guidelines

Landmark Studies and Evidence

Dialectical Behaviour Therapy (DBT): [16,18,19]

1. Linehan et al. (1991): First RCT of DBT vs. treatment-as-usual. DBT group had fewer suicide attempts, less medical severity of self-harm, fewer hospital days. Archives of General Psychiatry. PMID: 2064622

2. Linehan et al. (2006): DBT for high suicide risk in BPD. Reduced suicide attempts, medical severity, ED visits. JAMA Psychiatry. PMID: 16818865 [16]

3. Kothgassner et al. (2021): Meta-analysis of DBT for adolescent self-harm and suicidal ideation. Significant reductions in both. Psychological Medicine. PMID: 33875025 [19]

Mentalisation-Based Therapy (MBT): [17]

4. Bateman & Fonagy (1999, 2001, 2008): Series of RCTs showing MBT reduces self-harm, suicide attempts, hospitalisations. Effects sustained 8 years. American Journal of Psychiatry. PMID: 10484945, 11764789, 18381906

5. Barnicot et al. (2019): DBT vs. MBT comparison. Both effective; no significant difference in outcomes. Psychological Medicine. PMID: 30303061 [17]

Schema-Focused Therapy (SFT): [20]

6. Giesen-Bloo et al. (2006): SFT vs. TFP. SFT superior for BPD symptoms, dropout lower. Archives of General Psychiatry. PMID: 16818865

7. Assmann et al. (2024): DBT vs. SFT RCT. Both effective; SFT non-inferior to DBT. Psychotherapy and Psychosomatic Medicine. PMID: 38986457 [20]

Epidemiology: [3,5]

8. Grant et al. (2008): NESARC Wave 2 study. Prevalence 5.9%, high comorbidity burden. Journal of Clinical Psychiatry. PMID: 18426259 [5]

Neurobiology: [6,8,9]

9. Gunderson et al. (2018): Comprehensive review of BPD including neurobiology. Nature Reviews Disease Primers. PMID: 29795363. DOI: 10.1038/nrdp.2018.29 [2]

10. Ruocco et al. (2024): Updated review of neuroimaging in BPD. Amygdala hyperreactivity, prefrontal hypofunction. Current Psychiatry Reports. PMID: 39476273 [8]

Prognosis: [10,14]

11. Zanarini et al. (2012): McLean Study 10-year follow-up. 85% remission, low recurrence. Acta Psychiatrica Scandinavica. PMID: 22548761 [10]

12. Jørgensen et al. (2024): Adolescent BPD 5-year follow-up. Symptom reduction over time. Comprehensive Psychiatry. PMID: 38522259 [14]

Pharmacotherapy: [7]

13. Lieb et al. (2010): Cochrane review of pharmacotherapy for BPD. Limited evidence; modest effects on some symptoms. Cochrane Database of Systematic Reviews. PMID: 20166071 [7]

Comprehensive Reviews: [1,2,11]

14. Leichsenring et al. (2011): Major Lancet review of BPD. Lancet. PMID: 21195251. DOI: 10.1016/S0140-6736(10)61422-5 [3]

15. Leichsenring et al. (2024): Updated comprehensive review. World Psychiatry. PMID: 38214629. DOI: 10.1002/wps.21156 [11]

---

12. Examination Focus

Viva Questions and Model Answers

Exam Detail: Q1: A 24-year-old woman presents to the Emergency Department following an overdose of 20 paracetamol tablets. She has multiple scars on her forearms. She says her boyfriend threatened to leave her earlier today. How would you assess and manage this patient?

Model Answer:

"This presentation raises concern for possible Borderline Personality Disorder given the apparent relationship trigger, impulsive self-harm, and evidence of previous self-harm. My approach would involve:

Immediate Management:

• Assess paracetamol overdose risk: time of ingestion, amount, and check paracetamol level at 4 hours post-ingestion. Treat per poisoning protocol if indicated (activated charcoal if within 1 hour, N-acetylcysteine if above treatment line).
• Ensure medical stability before psychiatric assessment.

Psychiatric Assessment:

• Comprehensive risk assessment: current suicidal ideation, intent, plan, means, protective factors. Assess impulsivity.
• Detailed history: pattern of self-harm, triggers, relationships, childhood history (trauma), substance use.
• Screen for BPD criteria: fear of abandonment, unstable relationships, identity disturbance, impulsivity, affective instability, emptiness, anger, paranoia/dissociation.
• Mental state examination: mood, affect (labile?), thought content (suicidal ideation, paranoid ideas), perception (dissociation?).
• Screen for comorbidities: depression, PTSD, substance use, eating disorders.

Risk Formulation:

• Acute risk: Current suicidal ideation? Ongoing relationship crisis? Impulsivity level?
• Chronic risk: Pattern of repeated self-harm, but distinguish non-suicidal self-injury (emotion regulation) from suicide attempts.

Management:

• If medically stable and acute risk not high: avoid admission. Psychiatric admission often reinforces crisis behaviour in BPD and fosters dependency.
• Community-based crisis management preferred: brief supportive intervention, validate distress, review coping strategies, crisis plan.
• Safety plan: identify triggers, coping strategies, who to contact.
• Follow-up: GP or community mental health team within 24-48 hours.
• If not already known to services: refer to CMHT for assessment and potential psychotherapy (DBT, MBT).
• Avoid over-medication: no role for medication in acute crisis unless treating specific comorbid condition.

Long-term:

• Evidence-based psychotherapy (DBT preferred for recurrent self-harm).
• Address comorbidities.
• Collaborative crisis planning to reduce future ED presentations.

Key is balancing safety with avoiding iatrogenic harm from unnecessary admission and over-medicalisation."

---

Q2: What is the biosocial model of BPD?

Model Answer:

"The biosocial model, developed by Marsha Linehan, is the theoretical basis for Dialectical Behaviour Therapy and provides a compelling explanation for BPD development.

Two Components:

1. Biological Emotional Vulnerability:

   • Genetic and neurobiological predisposition to emotional dysregulation.
   • Three characteristics:
     • High sensitivity to emotional stimuli (low threshold for activation)
     • Intense emotional responses (high amplitude)
     • Slow return to baseline (prolonged physiological arousal)
   • This is temperamental and present from early life.

2. Invalidating Environment:

   • The child's emotional expressions are consistently dismissed, trivialised, or punished.
   • The child's internal experiences are not reflected or validated by caregivers.
   • The child is told their emotions are 'wrong', 'bad', or 'overreactions'.
   • Can range from overt abuse to subtle neglect or emotional unavailability.

Transaction:

• When an emotionally vulnerable child grows up in an invalidating environment, they fail to learn:
  • How to label and regulate emotions (never taught)
  • How to tolerate distress (never supported through it)
  • When to trust their own emotional responses (always told they're wrong)
  • How to form secure attachments (emotional needs not met consistently)

Outcome:

• The individual develops maladaptive strategies: self-harm for emotion regulation, impulsivity, intense anger, fear of abandonment, difficulty trusting own perceptions (identity disturbance).
• The pattern is self-perpetuating: emotional dysregulation leads to relationship chaos, which triggers more dysregulation.

Clinical Implication:

• This model explains why BOTH biology AND environment are necessary—neither alone is sufficient.
• It underpins DBT's dual focus on ACCEPTANCE (validate emotions) and CHANGE (teach skills).
• It de-pathologises the patient: their behaviour makes sense given their biology and history."

---

Q3: Compare and contrast Borderline Personality Disorder and Bipolar Affective Disorder.

Model Answer:

"These two conditions are frequently confused but have distinct features:

Key Discriminators:

• BPD: Mood reactivity to events, rapid shifts within hours, chronic pattern, interpersonal triggers, self-harm for emotion regulation.
• Bipolar: Distinct episodes, decreased need for sleep in mania, grandiosity, often family history, responds to lithium.

Comorbidity:

• They can coexist (10-20% comorbidity). This complicates both diagnosis and treatment.
• If unsure, longitudinal observation and mood charting can help differentiate.
• In BPD, mood shifts are reactive; in bipolar, episodes occur with less clear triggers."

---

Q4: What is the evidence for pharmacotherapy in BPD?

Model Answer:

"The evidence for pharmacotherapy in BPD is limited, and no medication is licensed for the disorder.

Overall Findings:

• Cochrane review (Lieb et al., 2010): modest benefits for some symptom domains; no evidence for treating core BPD itself; high dropout rates in trials; many studies low quality.
• NICE guideline (CG78): drug treatment should NOT be used specifically for BPD or for individual symptoms/behaviour associated with the disorder.

Symptom-Targeted Approaches:

1. Affective Dysregulation (mood instability, anxiety, anger):

   • SSRIs (e.g., fluoxetine): some evidence for reducing affective symptoms and impulsivity; effects modest; best evidence in this domain.
   • Mood stabilisers (lamotrigine, valproate): weak evidence; some studies show reduced anger/affective instability; not robust.

2. Impulsivity and Aggression:

   • SSRIs: may reduce impulsive aggression.
   • Low-dose second-generation antipsychotics (olanzapine, aripiprazole): some evidence for reducing impulsivity and aggression; short-term use only (max 3 months) due to metabolic risks.

3. Cognitive-Perceptual Symptoms (paranoia, dissociation):

   • Low-dose antipsychotics: weak evidence; symptoms often transient anyway; avoid long-term use.

Medications to Avoid:

• Benzodiazepines: risk of dependence, disinhibition worsens impulsivity, overdose risk. No good evidence.
• TCAs: highly toxic in overdose; no advantage over SSRIs.
• Long-term antipsychotics: risk of metabolic syndrome, tardive dyskinesia; limited evidence.

Comorbidities:

• If comorbid Major Depression, treat with antidepressants (SSRIs).
• If comorbid PTSD, consider trauma-focused therapy + SSRI.
• If comorbid Bipolar Disorder, treat bipolar with mood stabilisers.

Key Point:

• Psychotherapy (DBT, MBT, SFT) is first-line and has robust evidence.
• Medications are adjunctive at best, targeting specific symptoms or comorbidities, not BPD itself.
• Overreliance on medication is common and iatrogenic—leads to polypharmacy, side effects, and false hope for pharmacological 'cure'.
• Time-limited trials, regular review, avoid polypharmacy."

---

Q5: What is Dialectical Behaviour Therapy, and what is the evidence for it?

Model Answer:

"DBT is a comprehensive cognitive-behavioural therapy developed by Marsha Linehan specifically for BPD. It is the gold-standard psychological treatment.

Theoretical Basis:

• Biosocial model: emotional vulnerability + invalidating environment.
• Dialectical philosophy: balance of acceptance (validate emotions) and change (teach skills).
• Integration of CBT with mindfulness (Zen principles).

Structure (Standard DBT):

1. Individual therapy: weekly 1-hour sessions with primary therapist.
2. Skills training group: weekly 2-2.5 hour group teaching four modules.
3. Phone coaching: between-session support to generalise skills to real life.
4. Therapist consultation team: weekly meeting for therapist support and treatment adherence.

Duration: typically 12 months.

Four Skill Modules:

1. Mindfulness: Present-moment awareness; observe and describe without judgement; 'wise mind' (balance emotion and reason). Core skill underlying all others.
2. Distress Tolerance: Crisis survival techniques (e.g., TIPP: Temperature, Intense exercise, Paced breathing, Paired muscle relaxation); radical acceptance; self-soothing. Reduces impulsive self-harm.
3. Emotion Regulation: Identify and label emotions; reduce vulnerability (PLEASE: Physical illness, Eating, Avoid drugs, Sleep, Exercise); opposite action; problem-solving. Reduces emotional lability.
4. Interpersonal Effectiveness: DEAR MAN, GIVE, FAST skills for assertiveness, maintaining relationships, setting boundaries. Improves relationships and reduces abandonment fears.

Evidence:

• Multiple RCTs show DBT is superior to treatment-as-usual.
• Linehan et al. (2006): 50% reduction in suicide attempts vs. control.
• Reduces self-harm, ED presentations, psychiatric hospitalisations.
• Improves depression, hopelessness, anger.
• Effects sustained at 12-month follow-up.
• Meta-analysis (Kothgassner et al., 2021): DBT effective for adolescents with self-harm and suicidal ideation.

Challenges:

• Resource-intensive: requires trained therapists, group, phone coaching, supervision.
• Not widely available outside specialist centres.
• Dropout rates 30-40% in some studies.

Alternative Evidence-Based Therapies:

• Mentalisation-Based Therapy (MBT): comparable efficacy; may be better for attachment-related symptoms.
• Schema-Focused Therapy (SFT): some evidence superior to DBT in long-term outcomes.

Key Point: DBT is the gold-standard, with the most robust evidence base for BPD, particularly for reducing self-harm and suicidal behaviour."

---

13. Patient and Layperson Explanation

What is Borderline Personality Disorder (BPD)?

Borderline Personality Disorder (BPD), sometimes called Emotionally Unstable Personality Disorder (EUPD), is a mental health condition where you experience very intense emotions that can change rapidly, difficulty managing these emotions, and turbulent relationships. It often feels like being on an emotional rollercoaster that you can't get off.

What Are the Main Symptoms?

People with BPD often experience:

• Intense fear of being abandoned by people close to you, even if there's no real threat
• Unstable relationships that swing between thinking someone is perfect and then terrible
• Uncertainty about who you are – your sense of identity, goals, or values may keep changing
• Impulsive behaviours like reckless spending, unsafe sex, substance use, or binge eating
• Repeated self-harm or suicidal thoughts – often as a way to cope with overwhelming emotions
• Mood swings – your mood can change within hours, often triggered by something someone says or does
• Chronic feelings of emptiness – like there's a void inside that nothing can fill
• Intense anger that's hard to control, or frequent temper outbursts
• Feeling paranoid or disconnected from reality when stressed (e.g., feeling people are out to get you, or feeling "unreal")

You don't need to have all of these symptoms to have BPD – typically, five or more are present.

What Causes BPD?

BPD usually develops from a combination of:

1. Difficult childhood experiences – many people with BPD experienced trauma, abuse, neglect, or had their emotions dismissed or invalidated when growing up. Around 70-80% report childhood adversity.

2. Biological factors – some people are born with a more sensitive emotional "thermostat" – they feel emotions more intensely and take longer to calm down. This can run in families.

3. The combination matters – when a child who is emotionally sensitive grows up in an environment where their emotions are ignored or punished, they don't learn how to manage feelings in healthy ways. This is called the "biosocial model".

How Is BPD Diagnosed?

There's no blood test or scan for BPD. A mental health professional (psychiatrist or psychologist) will:

• Talk to you about your experiences, relationships, emotions, and behaviours
• Ask about your childhood and life history
• Assess whether you meet the criteria for BPD (usually five or more of nine specific features)

Diagnosis is usually made in early adulthood, though symptoms often start in the teenage years.

How Is BPD Treated?

The good news: BPD is treatable, and most people get significantly better.

1. Talking Therapy (Psychotherapy) – The Main Treatment

The most effective treatments are structured therapies that teach you skills to manage emotions and relationships:

• Dialectical Behaviour Therapy (DBT): This is the gold-standard treatment. It involves:

  • Individual therapy sessions (weekly)
  • Group skills classes (weekly) where you learn mindfulness, distress tolerance, emotion regulation, and interpersonal effectiveness
  • Phone coaching for crises
  • "Duration: Usually around 12 months"

• Mentalisation-Based Therapy (MBT): Focuses on understanding your own and other people's thoughts and feelings, which helps you respond more calmly in relationships.

• Schema-Focused Therapy: Addresses unhelpful core beliefs formed in childhood (e.g., "I'm unlovable"

  • "People will abandon me").

These therapies have strong evidence that they work – they can reduce self-harm by 50%, cut hospital admissions, and improve quality of life.

2. Medication – Limited Role

There's no medication specifically for BPD. However, medications may help with specific symptoms or conditions that often occur alongside BPD:

• Antidepressants (SSRIs) for depression or anxiety
• Mood stabilisers (sometimes) for severe mood swings
• Low-dose antipsychotics (short-term) for severe paranoia or impulsivity

Medication is NOT the main treatment – therapy is much more important.

3. Crisis Management

If you're in crisis (e.g., feeling suicidal or having urges to self-harm):

• Use your crisis plan (which you'll develop with your therapist)
• Try distress tolerance skills (e.g., holding ice, intense exercise, breathing techniques)
• Contact your crisis team or therapist
• Go to A&E if you're at immediate risk of harming yourself seriously

Hospital admission is usually avoided in BPD unless there's a severe, immediate risk, because it can sometimes make things worse by fostering dependency.

Can You Recover from BPD?

Yes – recovery is possible and common.

• Research shows that 85-90% of people with BPD achieve remission within 10 years – meaning they no longer meet the criteria for the diagnosis.
• Symptoms, especially impulsivity and self-harm, tend to reduce as you get older, even without treatment.
• With the right therapy, recovery is faster, and you can learn to have fulfilling relationships, work, and a good quality of life.

What Can You Do to Help Yourself?

• Engage with therapy – it's hard work, but it's the most effective treatment.
• Learn and practice skills – mindfulness, distress tolerance, emotion regulation techniques really do help.
• Build a crisis plan – identify your triggers and coping strategies in advance.
• Take care of physical health – sleep, exercise, and nutrition affect your emotions.
• Connect with others – peer support groups (online or in-person) can help you feel less alone.
• Be patient with yourself – recovery takes time, and setbacks are normal.

What Should Family and Friends Know?

• BPD behaviours (like intense anger, clinging, or self-harm) are driven by overwhelming emotional pain and fear of abandonment – not manipulation.
• Validate the person's emotions ("I can see you're really hurting") without necessarily agreeing with their behaviour.
• Set boundaries kindly but firmly.
• Encourage them to engage with treatment.
• Look after your own wellbeing too – supporting someone with BPD can be challenging.

Common Myths About BPD

❌ Myth: People with BPD are manipulative. ✅ Truth: Their behaviours are desperate attempts to cope with overwhelming emotions, not deliberate manipulation.

❌ Myth: BPD is untreatable. ✅ Truth: BPD is very treatable with the right therapy. Most people recover.

❌ Myth: People with BPD are dangerous. ✅ Truth: People with BPD are more likely to harm themselves than others. They are often victims of violence, not perpetrators.

❌ Myth: BPD is a lifelong sentence. ✅ Truth: Most people see significant improvement and many achieve full remission.

Where Can You Find Support?

• NHS Mental Health Services: Ask your GP for a referral to community mental health services or a specialist BPD service.
• Charities:
  • "Mind: mind.org.uk"
  • "Rethink Mental Illness: rethink.org"
  • "Emergence (BPD-specific): emergenceplus.org.uk"
• Crisis Support:
  • "Samaritans: 116 123 (24/7)"
  • Crisis text line: Text "SHOUT" to 85258

Remember

BPD is not your fault. It's a real condition with biological and environmental causes. With the right support and treatment, you can learn to manage your emotions, build stable relationships, and live a fulfilling life. Recovery is possible.

---

14. References

1. National Institute for Health and Care Excellence (NICE). Borderline Personality Disorder: Recognition and Management. Clinical Guideline CG78. 2009 (updated 2018). Available at: https://www.nice.org.uk/guidance/cg78

2. Gunderson JG, Herpertz SC, Skodol AE, Torgersen S, Zanarini MC. Borderline personality disorder. Nat Rev Dis Primers. 2018;4:18029. PMID: 29795363. DOI: 10.1038/nrdp.2018.29

3. Leichsenring F, Leibing E, Kruse J, New AS, Leweke F. Borderline personality disorder. Lancet. 2011;377(9759):74-84. PMID: 21195251. DOI: 10.1016/S0140-6736(10)61422-5

4. Shah R, Zanarini MC. Comorbidity of Borderline Personality Disorder: Current Status and Future Directions. Psychiatr Clin North Am. 2018;41(4):583-593. PMID: 30447726. DOI: 10.1016/j.psc.2018.07.009

5. Grant BF, Chou SP, Goldstein RB, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2008;69(4):533-545. PMID: 18426259

6. Guendelman S, Gaete MI, Morales B, Santelices M. [Neurobiology of borderline personality disorder]. Rev Med Chil. 2014;142(2):204-210. PMID: 24953109. DOI: 10.4067/S0034-98872014000200009

7. Bremner JD. Stress, the brain, and trauma spectrum disorders. Int Rev Neurobiol. 2020;152:1-22. PMID: 32450992. DOI: 10.1016/bs.irn.2020.01.004

8. Ruocco AC, Carcone D. Update on the Neurobiology of Borderline Personality Disorder: A Review of Structural, Resting-State and Task-Based Brain Imaging Studies. Curr Psychiatry Rep. 2024;26(11):634-652. PMID: 39476273. DOI: 10.1007/s11920-024-01553-w

9. Ellappan S, Costi R, Chowdhury S, Banwait K, Matheson K, Hayley S, Anisman H. Understanding borderline personality disorder: Clinical features, neurobiological insights, and therapeutic strategies. Prog Neuropsychopharmacol Biol Psychiatry. 2025;136:111403. PMID: 40404040. DOI: 10.1016/j.pnpbp.2025.111403

10. Brüne M. On the role of oxytocin in borderline personality disorder. Br J Clin Psychol. 2016;55(3):287-304. PMID: 26616386. DOI: 10.1111/bjc.12100

11. Leichsenring F, Fonagy P, Heim N, et al. Borderline personality disorder: a comprehensive review of diagnosis and clinical presentation, etiology, treatment, and current controversies. World Psychiatry. 2024;23(1):4-25. PMID: 38214629. DOI: 10.1002/wps.21156

12. Guilé JM, Boissel L, Alaux-Cantin S, de La Rivière SG. Borderline personality disorder in adolescents: prevalence, diagnosis, and treatment strategies. Adolesc Health Med Ther. 2018;9:199-210. PMID: 30538595. DOI: 10.2147/AHMT.S156565

13. Chapman J, Jamil RT, Fleisher C, Torrico TJ. Borderline Personality Disorder. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan. PMID: 28613633

14. Jørgensen MS, Bo S, Vestergaard M, et al. The course of borderline personality disorder from adolescence to early adulthood: A 5-year follow-up study. Compr Psychiatry. 2024;131:152478. PMID: 38522259. DOI: 10.1016/j.comppsych.2024.152478

15. Fariba KA, Gupta V, Kass E. Personality Disorder. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan. PMID: 32310518

16. May JM, Richardi TM, Barth KS. Dialectical behavior therapy as treatment for borderline personality disorder. Ment Health Clin. 2016;6(2):62-67. PMID: 29955449. DOI: 10.9740/mhc.2016.03.62

17. Barnicot K, Crawford M. Dialectical behaviour therapy v. mentalisation-based therapy for borderline personality disorder. Psychol Med. 2019;49(12):2060-2068. PMID: 30303061. DOI: 10.1017/S0033291718002878

18. Bohus M, Dyer AS, Priebe K, et al. Dialectical Behavior Therapy for Posttraumatic Stress Disorder (DBT-PTSD) Compared With Cognitive Processing Therapy (CPT) in Complex Presentations of PTSD in Women Survivors of Childhood Abuse: A Randomized Clinical Trial. JAMA Psychiatry. 2020;77(12):1235-1245. PMID: 32697288. DOI: 10.1001/jamapsychiatry.2020.2148

19. Kothgassner OD, Goreis A, Robinson K, et al. Efficacy of dialectical behavior therapy for adolescent self-harm and suicidal ideation: a systematic review and meta-analysis. Psychol Med. 2021;51(7):1057-1067. PMID: 33875025. DOI: 10.1017/S0033291721001355

20. Assmann N, Kriston L, Härter M, Schweiger U, Hautzinger M, Klein JP. The Effectiveness of Dialectical Behavior Therapy Compared to Schema Therapy for Borderline Personality Disorder: A Randomized Clinical Trial. Psychother Psychosom. 2024;93(5):297-309. PMID: 38986457. DOI: 10.1159/000538404

---